current mergers in AI drug discovery firms. Collect up to date reports on acquisitions, partnerships, and IPO filings among AI first pharma startups. Highlight market consolidation trends.
Current Mergers and Market Consolidation in AI Drug Discovery Firms
Curated sources covering 2025-2026 acquisitions and mergers, strategic partnerships and licensing, IPO activity, and broader biopharma consolidation. Primary-source evidence is limited in the retrieved set, so transaction trackers and trade reporting should be checked against company announcements and filings.
Acquisitions, mergers, and consolidation trackers
Sources identifying recent AI drug-discovery M&A, including platform mergers, acquisitions, asset purchases, and transactions reported with incomplete or nonuniform date and confirmation details.
newmarketpitch.comThe largest transaction in the 24-month window is Siemens / Dotmatics at $5.1B. That is a maj...
Not a therapeutic pipeline takeout — a high-signal biopharma-enabling infrastructure deal. Roche is folding Pa...
statnews.com22 Jun 2026Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekl...
Partnerships, licensing, and research collaborations
Reporting and company-issued material on AI-first drug-discovery collaborations with pharmaceutical companies, including Chai-Pfizer, Takeda-Iambic, Lilly-Insilico, and other arrangements.
Pfizer scientists will leverage Chai Discovery’s AI platform - including Chai-3, its most adv...
Jacob Bell
Iambic Therapeutics is one of many startups aiming to prove artificial intelligence can accel...
pharmexec.comInsilico Medicine Announces Global ...1-insilico-medicine-announces-global-rampd · Insilico and Lilly ...
genengnews.com6 Jul 2026Fay Lin, PhD
In May, Genesis Molecular AI and Incyte announced an expanded collaboration with a potential payoff that excee...
IPO filings and public-market activity
Sources for IPO registrations, potential listings, and biotech public-market conditions. The Generate Biomedicines report is transaction-specific, while SEC and market trackers provide filing and pipeline context.
pharmaphorum.compharmaphorum.com
Two other companies – AgomAb Therapeutics and Spyglass Pharma – are also on course to complete listings this w...
sec.govsec.gov
As filed with the Securities and Exchange Commission on July 14, 2026 · Registration No. 333-
xtalks.comAI-focused drug discovery company Isomorphic Labs secured $600 million to develop its AI drug design platform ...
At least six drug developers, led by Scribe Therapeutics, a developer of CRISPR-based genetic medicines, filed...
Save this answer
Create your account to keep this answer and continue from it later.
Sorry, Pandi could not find an answer.
Let's look at alternatives:
- Modify the query.
- Start a new thread.
- Remove sources (if manually added).
Related Content From The Pandipedia
latest funding rounds in spatial computing startups. Query will surface recent investment announcements and venture capital trends in XR and related fields.emerging startups fighting misinformation with blockchain. Tracks venture funding and product launches of companies using distributed ledgers for content verification. Offers innovation snapshots.academic partnerships advancing quantum education. Collect headlines on universities collaborating with industry to build quantum curricula.AI news moved fast in June and July 2026What strategies help biotech startups navigate competing CRISPR patents?financial performances of gaming ETFs. Provide up-to-date market trends for investors.latest breakthroughs in gene drive pest control. Generate a feed tracking recent papers, field trials, and regulatory hearings on gene drive insects and rodents. Emphasize both scientific progress and societal response.employee wellness programs offline initiatives. Find corporate announcements on phone free breaks and retreats. Shows business adoption momentum.How can parents set healthy tech boundaries for teens?corporate layoffs linked to automation 2025. Tracks companies reducing workforce due to AI deployment. Offers socioeconomic context and trend analysis.De risking biotech supply chains lessons from semiconductor manufacturing. Compare just in time pitfalls, diversification tactics, and quality standards between chips and biologics. Offer actionable steps for biotech firms to buffer shocks.latest breakthroughs in biochar commercialization. Tracks new plants, funding rounds, and regulations enabling large-scale biochar deployment.new records in utility-scale battery deployments. Reports gigawatt-hour milestones, project locations, and grid service contracts.Which Classic Arcade Cabinet Are You? Choose the option that feels most like youHow corporate learning ecosystems are evolving into lifelong employability platforms.. Analyzes LMS evolution, data-driven skill mapping, and partnership with MOOCs. Presents case studies of firms turning training into revenue streams.